Targeting DORIS Remission and LLDAS in SLE: A Review

Targeting DORIS Remission and LLDAS in SLE: A Review

Abstract Remission is the established therapeutic goal for patients with systemic lupus erythematosus (SLE) and is currently defined by the widely adopted Definition Of Remission In SLE (DORIS) criteria. Attainment of remission is rare in the clinical setting, thus an alternative, pragmatic treatmen...

Full description

Bibliographic Details
Main Authors: Agner R. Parra Sánchez, Ronald F. van Vollenhoven, Eric F. Morand, Ian N. Bruce, Rangi Kandane-Rathnayake, Gudrun Weiss, Raj Tummala, Hussein Al-Mossawi, Alessandro Sorrentino
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-10-01
Series:Rheumatology and Therapy
Subjects:
DORIS remission
LLDAS
Low disease activity
Remission
Systemic lupus erythematosus
Treat-to-target approach
Online Access:https://doi.org/10.1007/s40744-023-00601-w

Internet

https://doi.org/10.1007/s40744-023-00601-w

Similar Items